Primary lymphoma of the salivary gland is rare, with NHL being 5% of all extra nodal lymphomas and 2% of all salivary gland tumors. Most are low grade lymphomas with MALT lymphomas being the most common. DLBCL lymphomas are uncommon with most thought to be due to transformation from underlying low-grade lymphomas, postulated to arise in those with sialedinitis and Sjogren's syndrome. We report a rare case of DLBCL in a patient on treatment for Sjogren's Syndrome.
INTRODUCTION
Primary lymphoma of the salivary gland is rare, with NHL being 5% of all extra nodal lymphomas and 2% of all salivary gland tumors. [1] Most are low grade lymphomas with MALT lymphomas being the most common. DLBCL lymphomas are uncommon with most thought to be due to transformation from underlying low-grade lymphomas, postulated to arise in those with sialedinitis and Sjogren's syndrome. We report a rare case of DLBCL in a patient on treatment for Sjogren' Syndrome.
CASE HISTORY
A 63 Year old female, a diagnosed case of Sjogren's Syndrome since 2012 and on oral medicationsnamely tab. Prednisolone 5 mg od, tab. Azathioprine 50 mg od and tab. HCQ 200 mg od, presented with complaints of fever and painful swelling over her left parotid gland for 2 months duration. Initially received treatment for suspected bacterial parotitis with tab. Levofloxacin and linezolid. Since there was no response, a fine needle aspiration was done which revealed a low grade lymphoma at a general hospital and was referred to our hospital. She has no other comorbidities. On examination-her ECOG PS was 1, afebrile with no pallor or lymph nodes/ tensile enlargement. She had dry mouth and dry eyes. There was a 10*8 cm swelling of her left parotid gland, smooth surfaced however firm in consistency. skin was erythematous and non-tender, with dilated veins over the swelling. Systemic examination was unremarkable. Investigations at our hospital-showed a normal CBC, Biochemistry with negative viral markers. The LDH-152 U/L. there was no evidence of tumourlysis syndrome. The FNAC from the left parotid swelling was suspicious of a lymphoma, hence a trucut biopsy was done. The microscopy of which was reported as a malignant lymphoma and the IHC-showed neoplastic cells positive for CD20 with a high Ki-67. the cells were negative for CD3, CD5, CD23, lambda, Cyclin D1 and LMP-1, suggestive of a Diffuse large B-cell lymphoma. The CT imaging done-revealed a mutiloculated heterogeneously enhancing lesion in both the superficial and deep lobes of the left parotid, predominantly in the superficial lobe. The lesion infiltrated the skin poster laterally, the left para vertebral muscle and anterior wall of the external auditory canal and abutted the mastoid bone. Anteriorly, it abutted the masseter muscle and the left ramus of the mandible with loss of fat planes and compression of the retro mandibular vein. Medially, it extended to the left parapharyngeal space displacing the branches of the ECA and abutting the styloid bone. Few discrete enlarged enhancing lymph nodes were visualized in the left level II, III and V. There were atrophic sub mandibular and lacrimal glands. The thoracic and abdominal & pelvic imaging was unremarkable. The bone marrow examination showed no involvement of disease. is attributed to local T-cell-dependent antigen-driven proliferation of B cells that eventually become monoclonal and develop into primarily lowgrade MALT lymphoma. Sustained antigenic drive during lymphoma transformation is implied by the presence of selected immunoglobulin variable gene mutations and clonal heterogeneity in the hyper variable regions within the tumor cells. [6] It is known that MALT-lymphoma can progress to a diffuse large B-cell lymphoma but the criterion (on how) to define large-cell transformation is not universally accepted. [3] There are reports that diffuse large B-cell lymphoma with a nodal origin have a worse prognosis. [3] Our patient was diagnosed as a case of DLBCL arising from the parotid gland and not lymph node. The pathological examination showed no underlying low grade tumor which has commonly been seen in case studies. [7] this could probably explain her good response to chemotherapy. Patients with primary Sjogren's syndrome have risk factors for progression to lymphoma, such as persistent enlarged parotid glands, splenomegaly, lympadenopathy, palpable purpura, leg ulcers, peripheral nerve involvement, anemia, neutropenia, low-grade fever, low levels of C3 and C4, and mixed cryoglobulinemia. [4] No viruses or characteristic chromosomal abnormalities have been associated with these lymphomas in SS. [8] Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is rarer and is associated with poorer overall survival than EBV-negative DLBCL. [4] The LMP-1 which is a surrogate marker for EBV was negative in our patient. The outcomes of these patients with aggressive lymphomas have been reported to be dismal, with a median survival of only 1.8 years. [5] the survival for all lymphomas associated with SS varying from 0.5 to 1 years in a case series. [7] Whether the extra nodal origin, de novo origin of the tumor, lack of persistent enlargement of the parotid glands prior to development of the lymphoma and LMP-1 negativity portend a better outcome in our patient will be known in due course.
